ID24941A - ANTIGENAL VIRUS Dengue and treatment of dengue fever - Google Patents

ANTIGENAL VIRUS Dengue and treatment of dengue fever

Info

Publication number
ID24941A
ID24941A IDW20000566A ID20000566A ID24941A ID 24941 A ID24941 A ID 24941A ID W20000566 A IDW20000566 A ID W20000566A ID 20000566 A ID20000566 A ID 20000566A ID 24941 A ID24941 A ID 24941A
Authority
ID
Indonesia
Prior art keywords
dengue
antigenal
treatment
virus
fever
Prior art date
Application number
IDW20000566A
Other languages
Indonesian (id)
Inventor
Ingo Drexter
Gerd Sutter
Mary Jane Cardosa
Tio Phaik Hooi
Original Assignee
Bavarin Nordic Res Inst A S Cs
Gsf Forschungszentrum Umwelt
Univ Malaysia Sarawak
Venture Technologies Sdn Bhd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bavarin Nordic Res Inst A S Cs, Gsf Forschungszentrum Umwelt, Univ Malaysia Sarawak, Venture Technologies Sdn Bhd filed Critical Bavarin Nordic Res Inst A S Cs
Publication of ID24941A publication Critical patent/ID24941A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/10—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses
    • C07K16/1081—Togaviridae, e.g. flavivirus, rubella virus, hog cholera virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/24011—Poxviridae
    • C12N2710/24111—Orthopoxvirus, e.g. vaccinia virus, variola
    • C12N2710/24141—Use of virus, viral particle or viral elements as a vector
    • C12N2710/24143—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/24011—Flaviviridae
    • C12N2770/24111—Flavivirus, e.g. yellow fever virus, dengue, JEV
    • C12N2770/24122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Immunology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
IDW20000566A 1997-09-23 1998-09-21 ANTIGENAL VIRUS Dengue and treatment of dengue fever ID24941A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
MYPI9704411 1997-09-23

Publications (1)

Publication Number Publication Date
ID24941A true ID24941A (en) 2000-08-31

Family

ID=19749780

Family Applications (1)

Application Number Title Priority Date Filing Date
IDW20000566A ID24941A (en) 1997-09-23 1998-09-21 ANTIGENAL VIRUS Dengue and treatment of dengue fever

Country Status (4)

Country Link
EP (1) EP1021545A2 (en)
AU (1) AU754386B2 (en)
ID (1) ID24941A (en)
WO (1) WO1999015692A2 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2466413C (en) * 2001-12-04 2014-11-04 Bavarian Nordic A/S Flavivirus ns1 subunit vaccine
US7473424B2 (en) * 2003-01-31 2009-01-06 The Scripps Research Institute Anti-dengue virus antibodies and compositions
CU23586A1 (en) 2005-11-22 2010-10-30 Ct Ingenieria Genetica Biotech METHODS AND PROTEINS FOR THE PROPHLACTIC AND / OR THERAPEUTIC TREATMENT OF THE FOUR SEROTYPES OF THE DENGUE VIRUS AND OTHER FLAVIVIRUS
FR3042121A1 (en) 2015-10-08 2017-04-14 Jean-Marc Limacher ANTI-TUMOR COMPOSITION

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MY109299A (en) * 1990-08-15 1996-12-31 Virogenetics Corp Recombinant pox virus encoding flaviviral structural proteins
AU6093296A (en) * 1995-06-07 1996-12-30 Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services, The Infectious dengue 2 virus pdk-53 as quadravalent vaccine
EP0951555A2 (en) * 1996-09-24 1999-10-27 Bavarian Nordic Research Institute A/S Recombinant mva virus expressing dengue virus antigens, and the use thereof in vaccines

Also Published As

Publication number Publication date
AU754386B2 (en) 2002-11-14
WO1999015692A3 (en) 1999-06-24
AU1024999A (en) 1999-04-12
WO1999015692A2 (en) 1999-04-01
EP1021545A2 (en) 2000-07-26

Similar Documents

Publication Publication Date Title
ID17767A (en) VACCINES AND POLIPEPTIDES OF HIV COVER
ID21709A (en) ASSEMBLY OF SHAKERS FORMING SINGLE HOLES AND THE METHODS
DE69831755D1 (en) OPTOACUSTIC CONSTANCES AND METHOD OF USE
ID20463A (en) PENIL-AND AMINOFENYL-ALKILSULFONAMIDA AND UREA DECREASES
ID23575A (en) PIRAZOLOPIRIMIDINA-PIRAZOLOPIRIMIDINA AND PIRAZOLOTRIAZINA-PIRAZOLOTRIAZINA
ID27458A (en) EFERVESENT COMPOSITIONS AND DRY EFERVESENT GRANTS
ID21863A (en) COMPOUNDS OF KINOLIN AND KINAZOLIN USED IN THERAPY, SPECIFICALLY IN TREATMENT OF TYPICAL PROSTATIC HEPERPLASIA
ID23785A (en) HYDROCIANATION OF DIOLEPHINE AND ISOMERIZATION OF 2-ALKYL-3-MONOALCENANITRYL UNJUGGED
ID27614A (en) METHOD AND RADAS FOR WAVE THERAPY
ID27457A (en) COMPOSITION FOR HIV TREATMENT AND OTHER VIRUS INFECTIONS
ID22708A (en) GENERAL DEVELOPMENT AND METHODS
DE69835148D1 (en) SURGICAL CLIPS AND TERMINALS
ID19422A (en) PYRIDINA AND SUBSTITUTED BIFENYL
ID20321A (en) CRUDE PREVENTION Substances and METHODS OF USE
ID19548A (en) RECOMBINED MVA VIRUSES EXPRESSING FEATURES ANTIGENS AND FEVER USING THEMS IN VACCINES
ID26572A (en) COMPOSITION OF SKIN AND HAIR DAMPERS
ID24828A (en) PHARMACY COMPOSITIONS OF TIZOKSIANIDA AND NITAZOKSANIDA
DE69532106D1 (en) Maltose Phospharylase, Trehalose Phophorylase, Plesiomonas Strain, and Preparation of Trehalose
ID23258A (en) WITHDRAWAL-DELIVERY AND METHODS
ID28368A (en) PLANTS OF MICROSATELITE PLANTS AND METHODS OF USE
ID21847A (en) COMPOSITION OF INSECTICIDE AND METHODS OF USE
ID24463A (en) METHOD OF IMPROVING THE AVAILABILITY OF PHYSOFENADIN AND ITS DECLARATION
ID29396A (en) STRENGTHENING OF CLEANING AND CLEANING
ID18459A (en) PRODUCTION-JOINT 6-AMINOCAPRONITRIL AND HEXSAMETYLENADIAMINA
ID21862A (en) COMPOSITIONS OF INSECTICIDE AND MITISIDE